Wealth Enhancement Advisory Services’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
Other funds holding PHAT
6CM
Wealth Enhancement Advisory Services's PHAT Position: Q3 2026 in Review
Wealth Enhancement Advisory Services increased its Phathom Pharmaceuticals (PHAT) stake by 3% in Q3 2026, buying an estimated $5.31K and bringing the position to 19,294 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #3865.
Wealth Enhancement Advisory Services first reported a position in PHAT in Q2 2026 and has held it in 2 quarters since. The position peaked at $236K in Q2 2026. 161 funds tracked by Wall St. Rank hold PHAT as of Q3 2026.
- Wealth Enhancement Advisory Services held 19,294 shares of Phathom Pharmaceuticals worth $138K as of Q3 2026.
- Wealth Enhancement Advisory Services bought 563 Phathom Pharmaceuticals shares in Q3 2026, an estimated $5.31K.
- Phathom Pharmaceuticals made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #3865 holding.
- Wealth Enhancement Advisory Services first reported a position in Phathom Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
- Wealth Enhancement Advisory Services's Phathom Pharmaceuticals position peaked at $236K in Q2 2026.
- 161 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q3 2026.
Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.